CORRECTION OF NEUTROPHIL CHEMOTAXIS DEFECT IN PATIENTS WITH GAUCHER DISEASE BY LOW-DOSE ENZYME REPLACEMENT THERAPY

被引：26
|
作者：
ZIMRAN, A
ABRAHAMOV, A
AKER, M
MATZNER, Y
机构：
[1] HADASSAH UNIV HOSP, HEMATOL UNIT, JERUSALEM, ISRAEL
[2] HADASSAH UNIV HOSP, SHAARE ZEDEK MED CTR, GAUCHER CLIN, JERUSALEM, ISRAEL
[3] HADASSAH UNIV HOSP, DEPT PEDIAT, JERUSALEM, ISRAEL
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 1993年 / 43卷 / 01期
关键词：
CEREDASE; INFECTION; GLUCOCEREBROSIDASE;
D O I：
10.1002/ajh.2830430118
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We have recently described a chemotactic defect in severely afflicted Gaucher disease patients. Two of the patients were treated with low-dose intravenous enzyme replacement (Ceredase). Marked improvement in their hematological status, organomegaly, and growth was observed. In addition, their chemotactic defect and their tendency towards infections were corrected within 1 year of treatment.
引用
收藏
页码：69 / 71
页数：3
相关论文
共 50 条
  • [31] MiRNA Expression in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy
    Pawlinski, Lukasz
    Polus, Anna
    Tobor, Ewa
    Sordyl, Maria
    Kopka, Marianna
    Solnica, Bogdan
    Kiec-Wilk, Beata
    LIFE-BASEL, 2021, 11 (01): : 1 - 24
  • [32] Enzyme replacement therapy in romanian patients with type 1 Gaucher disease
    Sido, P. Grigorescu
    Drugan, C.
    Cret, V.
    Al-Kzouz, C.
    Denes, C.
    Zimmermann, A.
    Coldea, C.
    CLINICAL THERAPEUTICS, 2007, 29 : S118 - S118
  • [33] Low-dose versus high-dose therapy for Gaucher disease: goals and markers
    Hollak, Carla E. M.
    de Fost, Maalke
    Aerts, Johannes M. F. G.
    vom Dahl, Stephan
    BLOOD, 2007, 109 (01) : 387 - 387
  • [34] Effect of dose of enzyme replacement therapy with imiglucerase on bone crises in adolescents with Gaucher disease
    Kishnani, Priya
    Crissman, Blythe
    Mackey, Joanne
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S27 - S27
  • [35] Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease
    Altarescu, G
    Schiffmann, R
    Parker, CC
    Moore, DF
    Kreps, C
    Brady, RO
    Barton, NW
    BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (04) : 285 - 290
  • [36] Dose effect on enzyme replacement therapy (ERT) in type I gaucher disease.
    Altarescu, G
    Schiffmann, R
    O'Brady, R
    Barton, NW
    BLOOD, 1999, 94 (10) : 209A - 209A
  • [37] The successful treatment of some type I gaucher adult patients with very low dose enzyme replacement therapy
    Wilson, C. J.
    Spearing, R.
    Teague, L.
    Robertson, P.
    Blacklock, H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 64 - 64
  • [38] Enzyme replacement and gene therapy for Gaucher's disease
    Brady, RO
    Barton, NW
    LIPIDS, 1996, 31 : S137 - S139
  • [39] Gaucher disease and enzyme replacement therapy, Iranian experience
    Zaman, T.
    Roya, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 46 - 46
  • [40] Gaucher Disease Tested Alternative to Enzyme Replacement Therapy
    Gaucher, Morbus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (06)
12345